| Model Number |
B2060-200 |
| Medical Device Problem Code |
Material Rupture (1546)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
01/26/2023
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
The device is expected to be returned for investigation.It has not yet been received.A follow-up report will be submitted with all additional relevant information.The 5x100mm armada 35 and the 2x200mm armada 14 referenced in b5 are filed under separate medwatch report numbers.
|
| |
|
Event or Problem Description
|
|
It was reported that the patient presented with an acute myocardial infarction (mi).The procedure was to treat a heavily calcified, mildly tortuous, 90% stenosed, de novo lesion in the lesion in the right superior femoral artery (sfa).A 5.0x100mm on 135cm armada 35 balloon dilatation catheter (bdc) balloon was advanced to the lesion but ruptured before reaching nominal pressure during the first inflation.A 5.0x150mm 135cm armada 35 bdc was used to continue the procedure.A 6.0x200mm on 135cm armada 35 bdc balloon was advanced to the lesion but ruptured before reaching nominal pressure during the first inflation.A 6.0x100mm 150cm non-abbott device was used to continue the procedure.A 2.0x200mm on 150cm armada 14 bdc was advanced, but the balloon tip and distal shaft became stuck in the vessel while pulling back the balloon and separated.The plan was to schedule a retrieval of the separated device that remained in the patient, the next day, but due to cath lab availability, it was postponed one more day.The patient passed away on the second day after the angioplasty procedure due to the effects of the mi.In the physician's opinion, the death and mi, were not related to any of the abbott devices.No additional information was provided.
|
| |
|
Additional Manufacturer Narrative
|
|
Visual inspection was performed on the returned device.The reported balloon rupture was confirmed.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other similar incidents and/or complaints from this lot.The investigation determined the reported balloon rupture appears to be related to operational context.It was reported by the account that per the physician opinion, the armada 35, did not cause or contribute to the patient's death in any way.The reported patient effect of death is listed in the percutaneous transluminal angioplasty (pta), armada 35 / armada 35 ll, global, instructions for use as a known patient effect.There is no indication of a product quality issue with respects to the design, manufacture, or labeling of the device.
|
| |
|
Search Alerts/Recalls
|